These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


323 related items for PubMed ID: 9137090

  • 1. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.
    Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D.
    Am J Pathol; 1997 May; 150(5):1647-59. PubMed ID: 9137090
    [Abstract] [Full Text] [Related]

  • 2. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.
    Iredale JP, Benyon RC, Arthur MJ, Ferris WF, Alcolado R, Winwood PJ, Clark N, Murphy G.
    Hepatology; 1996 Jul; 24(1):176-84. PubMed ID: 8707259
    [Abstract] [Full Text] [Related]

  • 3. [Fibrogenesis and fibrolysis in the liver].
    Herbst H, Schuppan D, Milani S.
    Verh Dtsch Ges Pathol; 1995 Jul; 79():15-27. PubMed ID: 8600680
    [Abstract] [Full Text] [Related]

  • 4. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB, Li DG, Lu HM.
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [Abstract] [Full Text] [Related]

  • 5. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis.
    Kossakowska AE, Edwards DR, Lee SS, Urbanski LS, Stabbler AL, Zhang CL, Phillips BW, Zhang Y, Urbanski SJ.
    Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979
    [Abstract] [Full Text] [Related]

  • 6. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis.
    Arthur MJ, Mann DA, Iredale JP.
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S33-8. PubMed ID: 9792032
    [Abstract] [Full Text] [Related]

  • 7. Cellular distribution of transcripts for tissue inhibitor of metalloproteinases 1 and 2 in human hepatocellular carcinomas.
    Nakatsukasa H, Ashida K, Higashi T, Ohguchi S, Tsuboi S, Hino N, Nouso K, Urabe Y, Kinugasa N, Yoshida K, Uematsu S, Ishizaki M, Kobayashi Y, Tsuji T.
    Hepatology; 1996 Jul; 24(1):82-8. PubMed ID: 8707287
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Jul; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential expression of matrix-metalloproteinase-1 and -2 genes in normal and fibrotic human liver.
    Milani S, Herbst H, Schuppan D, Grappone C, Pellegrini G, Pinzani M, Casini A, Calabró A, Ciancio G, Stefanini F.
    Am J Pathol; 1994 Mar; 144(3):528-37. PubMed ID: 8129038
    [Abstract] [Full Text] [Related]

  • 13. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K, Lahme B, Tag CG, Gressner AM.
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [Abstract] [Full Text] [Related]

  • 14. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period.
    Das SK, Yano S, Wang J, Edwards DR, Nagase H, Dey SK.
    Dev Genet; 1997 Feb; 21(1):44-54. PubMed ID: 9291579
    [Abstract] [Full Text] [Related]

  • 15. Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.
    González-Cuevas J, Bueno-Topete M, Armendariz-Borunda J.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1544-54. PubMed ID: 16928215
    [Abstract] [Full Text] [Related]

  • 16. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
    Sun W, Gui S, Wu L, Wang H, Wei W.
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
    [Abstract] [Full Text] [Related]

  • 17. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis.
    Dudás J, Kovalszky I, Gallai M, Nagy JO, Schaff Z, Knittel T, Mehde M, Neubauer K, Szalay F, Ramadori G.
    Am J Clin Pathol; 2001 May; 115(5):725-35. PubMed ID: 11345837
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
    Sakaida I, Hironaka K, Kimura T, Terai S, Yamasaki T, Okita K.
    Life Sci; 2004 Mar 19; 74(18):2251-63. PubMed ID: 14987950
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.